Abstracts tagged "guidelines"

Abstract Number: 1175 • ACR Convergence 2021
Best Practice Guidelines for Telehealth in Rheumatology: An Initiative by the Arab League of Associations for Rheumatology
Nelly Ziade¹, Ihsane Hmamouchi², Lina El Kibbi³, Melissa Daou⁴, Nizar Abdulateef⁵, Fatemah Abutiban⁶, Bassel Elzorkany⁷, Khalid Al Naqbi⁸, Wafa Hamdi⁹, Chafia Dahou-Makhloufi¹⁰, Samar Al Emadi¹¹, Hussein Halabi¹², Radouane Niamane¹³, Mervat Eissa⁷, Manal El Rakawi¹⁴, Sima Abu Al Saoud¹⁵, Soad Hashad¹⁶ and Basel Masri¹⁷, ¹Rheumatology Department, Saint-Joseph Medical University and Hotel-Dieu de France Hospital, Beirut, Lebanon, ²Rheumatology Unit, Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco, ³Specialized Medical Center, Riyadh, Saudi Arabia, ⁴Faculty of Medicine, Saint-Joseph Medical University, Beirut, Lebanon, Beirut, Lebanon, ⁵Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq, ⁶Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah Hospital, Kuwait City, Kuwait, ⁷Cairo University, Cairo, Egypt, Cairo, Egypt, ⁸Al Ain Hospital, AL AIN, United Arab Emirates, ⁹Rheumatology Department, Kassab Institute of Orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia, ¹⁰Rheumatology Department, Mohamed Lamine Debaghine University Hospital, Bab El Oued, Algiers, Algeria, ¹¹Hamad medical corporation, Doha, Qatar, ¹²King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, ¹³Department of Rheumatology, Military Hospital Avicenne, University Cadi Ayyad, Marrakesh, Morocco, ¹⁴Rheumatology Department, Douera Hospital, Faculty of Medicine, Saad Dahlab, Blida, Algeria, ¹⁵Makassed Hospital, East Jerusalem, Palestine, East Jerusalem, Palestinian Territories, ¹⁶Tripoli Children Hospital, Tripoli, Libya / The University of Tripoli, Libya, Tripoli, Libya, ¹⁷Jordan Hospital, Amman, Jordan
Background/Purpose: The need for telehealth is increasing and will undeniably play a role in the field of health care services, even beyond the COVID-19 era.…
Abstract Number: 2079 • 2019 ACR/ARP Annual Meeting
Impact of Eliminating the Bouted Minutes Requirement in the New 2018 Physical Activity Guidelines for Americans on Gender Disparity in Guideline Attainment for Persons with or at High Risk of Knee Osteoarthritis
Alison Chang¹, Jing Song ², Julia (Jungwha) Lee ³, Rowland Chang ³, Pamela Semanik ¹ and Dorothy Dunlop ³, ¹Northwestern University Feinberg School of Medicine, Chicago, ²Northwestern University Feinberg School of Medicine, Worthington, OH, ³Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: The 2018 Physical Activity (PA) Guidelines no longer require PA to occur in bouts of ≥ 10 minutes for meeting the weekly 150-min moderate-to-vigorous…
Abstract Number: 1181 • 2018 ACR/ARHP Annual Meeting
Hydroxychloroquine: Do We All See Eye to Eye? a Single-Site Analysis of Hydroxychloroquine Dosing Compared to 2016 American Academy of Ophthalmology Guidelines
Vaneet K. Sandhu¹, Noopur Goel² and Jamileh Hanna², ¹Division of Rheumatology, Loma Linda University, Loma Linda, CA, ²Loma Linda University, Loma Linda, CA
Background/Purpose: Hydroxychloroquine is universally recommended to treat patients with SLE, stressing the importance of appropriate dosing. The 2016 American Academy of Ophthalmology (AAO) guidelines recommend…
Abstract Number: 1243 • 2018 ACR/ARHP Annual Meeting
A Quality Improvement Initiative to Increase Adherence to Hydroxychloroquine Dosing Guidelines at an Academic Medical Center
Ryan Jessee, Stephanie L. Giattino, Atul Kapila, Katherine Kaufman, Jon Golenbiewski, Brian J. Andonian, David Leverenz and Lisa Criscione-Schreiber, Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC
Background/Purpose: In 2016, the American Academy of Ophthalmology published revised guidelines on HCQ dosing, recommending a maximum daily dose of 5mg/kg actual body weight as…
Abstract Number: 2390 • 2017 ACR/ARHP Annual Meeting
Trends and Predictors of Guideline Adherence for Glucocorticoid-Induced Osteoporosis Prevention in an Early Rheumatoid Arthritis Cohort
Stephanie Gottheil¹, Orit Schieir², Carter Thorne³, Carol A Hitchon⁴, Diane Tin⁵, Edward C. Keystone⁶, Gilles Boire⁷, Boulos Haraoui⁸, Susan J. Bartlett⁹, Vivian P. Bykerk¹⁰ and Janet E. Pope¹¹, ¹University of Western Ontario, LONDON, ON, Canada, ²McGill University, Montreal, ON, Canada, ³University of Toronto, Newmarket, ON, Canada, ⁴University of Manitoba, Winnipeg, MB, Canada, ⁵The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ⁶Mt. Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁷Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, ⁸Institute de Rheumatologie, Montreal, QC, Canada, ⁹Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ¹⁰2-005, Mt Sinai Hospital, Toronto, ON, Canada, ¹¹Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada
Background/Purpose: RA patients are at a high risk of osteoporosis and fracture, in part due to frequent glucocorticoid use. Despite recommendations from ACR guidelines on…
Abstract Number: 2395 • 2017 ACR/ARHP Annual Meeting
Recommendations on the Management of Rheumatoid Arthritis in Patients with Cancer: A Systematic Review of Clinical Practice Guidelines and Consensus Statements
Maria A. Lopez-Olivo¹, Ines Colmegna², Aliza Matusevich¹, Susan Ruyu Qi³, Natalia Zamora¹, Robin Sharma¹, Gregory Pratt⁴ and Maria Suarez-Almazor¹, ¹Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, ²Division of Rheumatology, Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada, ³Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada, Montreal, QC, Canada, ⁴Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX
Background/Purpose: To compare the recommendations of clinical practice guidelines (CPGs) and consensus statements (CSs) regarding the management of rheumatoid arthritis (RA) in patients with cancer.…
Abstract Number: 2414 • 2017 ACR/ARHP Annual Meeting
Knowledge and Adherence to Current Immunization Recommendations in Patients with Rheumatoid Arthritis in Mexico
Andrea Sofia Cepeda-Perez¹, Nina Tello Winniczuk² and Alejandro Diaz-Borjon², ¹Internal Medicine, Hospital Angeles Lomas, Huixquilucan, Estado de Mexico, Mexico, ²Internal Medicine and Rheumatology, Hospital Angeles Lomas, Huixquilucan, Estado de Mexico, Mexico
Background/Purpose: Patients with RA have a two to four-fold increased risk of developing infections than the general population. This is due to both, the disease…
Abstract Number: 424 • 2016 ACR/ARHP Annual Meeting
Adherence to American College of Rheumatology Immunization Recommendations for Rheumatoid Arthritis Patients in a Tertiary Care Health System and Opportunities to Close the Gap
Maryann Kimoto¹, Mary Chester M. Wasko² and Tarun S. Sharma³, ¹Internal Medicine, Internal Medicine Residency Program, Allegheny Health Network, Pittsburgh, PA, ²Lupus Center, Pittsburgh, PA, ³Rheumatology, Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA
Background/Purpose: A total of 85 adult RA patients were identified. The mean age was 61.5 yrs, 84.7% were female, 85.9% were Caucasian, and the mean…
Abstract Number: 2243 • 2016 ACR/ARHP Annual Meeting
The Paucity of the Evidence Base for American College of Rheumatology Practice Guidelines
Ali Duarte-Garcia¹, Richard Zamore² and John B. Wong², ¹Medicine, Tufts Medical Center, Boston, MA, ²Tufts Medical Center, Boston, MA
Background/Purpose: The American College of Rheumatology (ACR) practice guidelines establish U.S. and international treatment recommendations and hence performance measures and research priorities, so we sought…
Abstract Number: 2512 • 2016 ACR/ARHP Annual Meeting
Secular Trends of Sustained Remission in Rheumatoid Arthritis, a Nationwide Register Study in Sweden
Jon T. Einarsson¹, Minna Willim¹, Sofia Ernestam², Tore Saxne¹, Pierre Geborek¹ and Meliha C. Kapetanovic¹, ¹Lund University, Skane University Hospital, Department of Rheumatology, Lund, Sweden, Lund, Sweden, ²Centre of Rheumatology, Stockholm County Council, Stockholm, Sweden, Stockholm, Sweden
Background/Purpose: Remission has become a treatment goal in rheumatoid arthritis (RA) especially after the introduction of biologic treatment in 1999. The Swedish quality registry…
Abstract Number: 380 • 2015 ACR/ARHP Annual Meeting
Osteoporosis Screening and Treatment of Rheumatoid Arthritis Patients at a Teaching Institution
Sheena Ogando¹, Calie Santana², Irene Blanco³ and Barbara Mendez¹, ¹Rheumatology, Montefiore Medical Center, Bronx, NY, ²Medicine, Montefiore Medical Center, Bronx, NY, ³Rheumatology, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Glucocorticoids are effective at treating rheumatologic diseases but are known to increase fracture risk. In 2010, the ACR developed recommendations for the prevention…
Abstract Number: 924 • 2015 ACR/ARHP Annual Meeting
Patient and Provider Factors in Optimal Gout Management
Brian Coburn¹, Kayli Bendlin², Harlan Sayles¹ and Ted R. Mikuls¹, ¹Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ²Pharmacy Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE
Background/Purpose: Gout is the most common inflammatory arthritis worldwide. Despite its prevalence and the availability of effective therapies, studies have consistently characterized gout quality of…
Abstract Number: 1032 • 2015 ACR/ARHP Annual Meeting
Adherence Patterns to American Academy of Ophthalmology Guidelines for Hydroxychloroquine Baseline Screening: Quality Assurance Assessment Utilizing Highmark Claims Data
Christina Payne¹, Patricia Gladowski², James Byers Jr.², Amy Tang³ and Mary Chester M. Wasko⁴, ¹Allegheny General Hospital Department of Medicine, Allegheny Health Network, Pittsburgh, PA, ²Enterprise Knowledge Discovery, Highmark Health, Pittsburgh, PA, ³Asthma, Allergy and Autoimmunity Institute, Allegheny Health Network, Pittsburgh, PA, ⁴Lupus Center, Pittsburgh, PA
Background/Purpose: Hydroxychloroquine (HCQ) is an antimalarial agent used commonly to treat selected autoimmune rheumatic diseases because of its therapeutic benefits, low cost, and favorable safety…
Abstract Number: 349 • 2015 ACR/ARHP Annual Meeting
Comparison Between the American Recommendations and the Japanese Guidelines for Glucocorticoid-Induced Osteoporosis in Japanese Patients with Rheumatoid Arthritis
Takefumi Furuya, Shigeki Momohara, Atsuo Taniguchi and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: In 2014, the Japanese Society for Bone and Mineral Research (JSBMR) updated their guidelines for the management and treatment of glucocorticoid-induced osteoporosis (GIO) and…
Abstract Number: 1350 • 2014 ACR/ARHP Annual Meeting
Practice What You Preach? Suboptimal Guideline Adherence By Rheumatologists in Patients with Rheumatoid Arthritis
Nienke Lesuis¹, Ronald van Vollenhoven², Marlies Hulscher³ and Alfons den Broeder¹, ¹Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ²Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, ³IQ Healthcare, Radboud University Medical Centre, Nijmegen, Netherlands
Background/Purpose: Tight control based treatment principles of rheumatoid arthritis (RA) are superior to usual care and therefore recommended in many (inter)national guidelines.1-3 Unfortunately guideline adherence…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].